The Seattle Vaccine Trials Unit (VTU), led by Dr. Julie McElrath, director of Fred Hutch division of Vaccine and Infectious Disease implements an array of studies researching HIV and other infectious diseases.
In the world of HIV vaccine research, the VTU is one of the 22 research sites within the HIV Vaccine Trials Network (HVTN), the world's largest publicly funded multi-disciplinary international collaboration. The HVTN network is funded to conduct phase I, II, and III clinical trials designed to test the safety and efficacy of HIV vaccines. As a local site of the HVTN, the Seattle VTU works to enroll volunteers in a number of research studies.
Located on Seattle's First Hill, the VTU is responsible for the recruitment, selection and enrollment of local volunteers and clinical monitoring of volunteers. Since opening in 1987, the Seattle VTU has worked with local community members who are interested in participating in research and has provided education to the local community. We work with many community based organizations such as African American Reach and Teach Ministries , Entre Hermanos , Gay City , Multicultural HIV/Hepatitis Action Network and Lifelong AIDS Alliance.
Together with the help of our volunteers, we hope to end the HIV/AIDS pandemic.
NOTE : This is a part-time, hourly position. Availability for Monday evening meetings and a flexible schedule will include weekday, nights and weekends on a \u201cas needed\u201d basis. Anticipated hours are roughly 10 hrs/week.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.